On March 26–27, the 14th CIAPH Digital Summit for the Pharmaceutical & Healthcare Industry was held at the Chateau Star River Pudong. Centered on the theme “Anchoring High-Value Business Scenarios”, the event brought together digital leaders and industry experts to discuss practical pathways for advancing intelligent transformation across the pharmaceutical sector.

At the summit, Morimatsu presented its vision, “Digital Intelligence in Action: Powering a Smarter Future”, highlighting its latest R&D achievements and real-world capabilities in digital intelligence services. With a strong focus on customer needs, Morimatsu addresses key challenges across the pharmaceutical value chain. The company provides integrated engineering and digital solutions designed to support the development of “smart plants”. Its end-to-end service offering—spanning engineering, construction, and operations and maintenance—was a major highlight of the event.

At the exhibition, Morimatsu highlighted four core digital intelligence business segments, showcasing both the technical strength and real-world value of its smart solutions for pharmaceutical equipment:

1.Mo-DTS Digital Twin Solutions
By integrating an Engineering Data Center with VR/AR visualization, construction monitoring, and 3D scanning and modeling, Morimatsu enables end-to-end digital visibility and control across the entire engineering and construction lifecycle.

2.Mo-OES Smart Operations Solutions
Built around visualized operations, predictive maintenance, a spare parts marketplace, and after-sales support, this solution delivers a comprehensive, lifecycle-based O&M system. Leveraging advanced digital technologies, it helps ensure efficient, reliable equipment performance and management.

3.Mo-PES Multimodal AI Solutions
From data collection and analysis to governance and multimodal AI modeling, Morimatsu provides a full-stack approach that helps organizations transform data into strategic assets and strengthen long-term competitive advantage.

4.Mo-DRS Digitalization & Automation Solutions
Focusing on areas such as intelligent sterile automated sampling, MES implementation, and SCADA systems, Morimatsu offers end-to-end planning and consulting services to support the development of smart, fully digitalized plants.

At the exhibition, Morimatsu’s BCS Sterile Automatic Sampling System drew significant attention from attendees.

The BCS (BioCruise Sampler) Collaborative Robot Sterile Automatic Sampling System is an advanced automated solution designed specifically for biopharmaceutical manufacturing environments. By enabling fully unmanned sampling, the system minimizes the risk of cross-contamination at the source, ensuring compliance, sample integrity, and process stability. At the same time, multi-robot collaboration and high-precision control technologies improve sampling efficiency and help increase overall production capacity.

In addition, Morimatsu presented a broader portfolio of digital intelligence solutions spanning the entire pharmaceutical value chain, demonstrating new possibilities for end-to-end enablement in smart pharmaceutical manufacturing. The showcase attracted strong interest from industry professionals, many of whom engaged in in-depth discussions with the Morimatsu team.

Throughout the event, Morimatsu delivered live presentations and video demonstrations to illustrate its approach to digital transformation. Attendees also gained deeper insights into the company’s MES implementation services, with practical use cases and solution strategies tailored to address common industry challenges. Morimatsu’s expertise and high-quality service offerings were widely recognized and well received by participants.

Morimatsu’s participation in the Digital Health Summit marked an important opportunity to showcase its capabilities and engage with industry peers on the future of pharmaceutical digitalization. Seizing this opportunity, Morimatsu collaborated with industry peers to explore new pathways for digital and intelligent transformation in healthcare. Looking ahead, the company will continue to expand its digital intelligence offerings across the pharmaceutical value chain, breaking down silos, enhancing collaboration, and driving innovation in pharmaceutical manufacturing.

About Morimatsu LifeSciences

Morimatsu LifeSciences is one of the key business segments of Morimatsu International Holdings Company Limited (Morimatsu International, Stock Code: 2155.HK). It primarily consists of Shanghai Morimatsu Pharmaceutical Equipment Engineering Co., Ltd., Morimatsu (Suzhou) LifeSciences Company Limited, Shanghai Morimatsu Biotechnology Co., Ltd., Shanghai Mori-Biounion Technology Co., Ltd., Shanghai MoriSora Technology Co., Ltd., Bioengineering AG and Pharmadule Morimatsu AB, along with their subsidiaries.

We specialize in providing core equipment, process systems, and comprehensive digital-intelligent plant solutions along with corresponding services for industries including pharmaceuticals, biopharmaceuticals, medical aesthetics, fast-moving consumer goods (FMCG, including cosmetics, food, health products, etc.), and data centers. The company boasts an elite team composed of seasoned experts across multiple fields, including process R&D, engineering design, high-end manufacturing, validation consulting, production execution, and digital-intelligent operations. The team members possess extensive experience in industries such as pharmaceuticals, biopharmaceuticals, medical aesthetics, FMCG, and data centers. They are well-versed in the characteristics and process flows of diverse products, enabling them to provide customized process solutions tailored to client needs from the conceptual design stage onward.

Morimatsu LifeSciences has established a global strategic presence, with advanced R&D, design centers, and manufacturing bases across different countries and regions, complemented by a comprehensive service network covering Europe, America, Asia-Pacific, and emerging markets. The company's international professional team has successfully delivered customized solutions to over 40 countries and regions, accumulating rich experience in global project execution.

As a multinational enterprise mastering core process technologies, modular construction, and digital intelligent plant expertise, Morimatsu LifeSciences is committed to meeting the production equipment demands of global industries, including pharmaceuticals, biopharmaceuticals, medical aesthetics, FMCG, and data centers. Through continuous innovation and optimization, the company supports domestic enterprises in accelerating the strategic localization of core and high-end equipment, driving industry advancement. Simultaneously, the company actively expands overseas markets, deepening its "globalization" business development strategy to contribute Morimatsu's expertise to the global life sciences and related industries.